An unusual case of CD4+CD7+CD56+acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia

被引:24
作者
Anargyrou, K
Paterakis, G
Boutsis, D
Politou, M
Papadhimitriou, SI
Siakandaris, M
Vassiliadis, J
Androulakis, A
Meletis, J
Rombos, J
Tassiopoulou, A
Vaiopoulos, G
机构
[1] Univ Athens, Laikon Gen Hosp, Dept Internal Med 1, GR-10679 Athens, Greece
[2] G Gennimatas Gen Dist Hosp Athens, Dept Immunol, Athens, Greece
[3] G Gennimatas Gen Dist Hosp Athens, Natl Histocompatibil Ctr, Athens, Greece
[4] G Gennimatas Gen Dist Hosp Athens, Dept Hematol, Athens, Greece
关键词
acute unclassified leukemia; dendritic cell acute leukemia; myeloid/nk acute leukemia;
D O I
10.1034/j.1600-0609.2003.00098.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 dendritic cell (DC2) acute leukemia has been recently described. We report here an unusual case of a 17-yr-old adolescent with overlapping features of DC2 and myeloid/NK cell precursor acute leukemia as defined by Suzuki et al. The patient presented with lymphadenopathy and hepatosplenomegaly without extranodal manifestations in skin or elsewhere. The morphologic, cytochemical and immunophenotypic features were compatible with those described in DC2 acute leukemia, with co-expression of CD4, CD56 and CD123 antigens. The novel markers BDCA-4 and BDCA-2 considered specific for DC2s were co-expressed. However, bright CD7 positivity along with a dim expression of CD33 (57%) and CD117 (27%) were also noted. Additionally, there was bright expression of NG2 monoclonal antibody 7.1, a frequent finding in myeloid/NK cell precursor acute leukemia. The interpretation of the immunophenotypic pro. le leads to the hypothesis on the existence of borderline cases between DC2 and myeloid/NK cell precursor acute leukemia. Still, other hypotheses can not be overlooked, such as the possibility for a kind of variant monoblastic leukemia or of another rare entity of acute unclassified leukemia.
引用
收藏
页码:294 / 298
页数:5
相关论文
共 16 条
[1]   Identification of a leukemic counterpart of the plasmacytoid dendritic cells [J].
Chaperot, L ;
Bendriss, N ;
Manches, O ;
Gressin, R ;
Maynadie, M ;
Trimoreau, F ;
Orfeuvre, H ;
Corront, B ;
Feuillard, J ;
Sotto, JJ ;
Bensa, JC ;
Brière, F ;
Plumas, J ;
Jacob, MC .
BLOOD, 2001, 97 (10) :3210-3217
[2]   Blastic natural killer cell leukemia/lymphoma: A clinicopathologic study [J].
DiGiuseppe, JA ;
Louie, DC ;
Williams, JE ;
Miller, DT ;
Griffin, CA ;
Mann, RB ;
Borowitz, MJ .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (10) :1223-1230
[3]   BDCA-2, BDCA-3 and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood [J].
Dzionek, A ;
Fuchs, A ;
Schmidt, P ;
Cremer, S ;
Zysk, M ;
Miltenyi, S ;
Buck, DW ;
Schmitz, J .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6037-6046
[4]   Clinical and biologic features of CD4+CD56+ malignancies [J].
Feuillard, J ;
Jacob, MC ;
Valensi, F ;
Maynadié, M ;
Gressin, R ;
Chaperot, L ;
Arnoulet, C ;
Brignole-Baudouin, F ;
Drénou, B ;
Duchayne, E ;
Falkenrodt, A ;
Garand, R ;
Homolle, E ;
Husson, B ;
Kuhlein, E ;
Le Calvez, G ;
Sainty, D ;
Sotto, MF ;
Trimoreau, F ;
Béné, MC .
BLOOD, 2002, 99 (05) :1556-1563
[5]  
Kameoka J, 1998, AM J CLIN PATHOL, V110, P478
[6]  
KURTZBERG J, 1989, BLOOD, V73, P381
[7]   CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets:: a study of 21 cases by the Groupie Francais de Cytogenetique Hematologique [J].
Leroux, D ;
Mugneret, F ;
Callanan, M ;
Radford-Weiss, I ;
Dastugue, N ;
Feuillard, J ;
Le Mée, F ;
Plessis, G ;
Talmant, P ;
Gachard, N ;
Uettwiller, F ;
Pages, MP ;
Mozziconacci, MJ ;
Eclache, V ;
Sibille, C ;
Avet-Loiseau, H ;
Lafage-Pochitaloff, M .
BLOOD, 2002, 99 (11) :4154-4159
[8]  
LISO V, 1992, LEUKEMIA, V6, P10
[9]  
Mauvieux L, 1999, BRIT J HAEMATOL, V107, P674
[10]  
Paietta E, 2001, AM J HEMATOL, V66, P189, DOI 10.1002/1096-8652(200103)66:3<189::AID-AJH1043>3.0.CO